Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate)

This study investigates the safety and efficacy of injecting N-butyl-2-cyanoacrylate (Histoacryl®) into the pancreatic parenchyma during pancreaticoduodenectomy (PD) to enhance the security of the pancreaticojejunostomy (PJ) anastomosis and reduce postoperative pancreatic fistula (POPF) rates.

Trial Details

NCT ID
NCT07132541
Phase
PHASE1
Sponsor
Minia University
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • Pancreatic parenchymal injection of N-butyl-2-cyanoacrylate(Histoacryl®)
Locations (sample)
  • Minya, Minya Governorate, Egypt|28.09193,30.75813

Key Eligibility Criteria

  • Patients undergoing pancreaticoduodenectomy for malignant lesions meeting the curative treatment intent in accordance with clinical guidelines.
  • Soft pancreatic texture.
  • Small main pancreatic duct diameter (\<3 mm).
  • Informed consent obtained.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →